{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:08:25Z","timestamp":1790165305946,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.rpth.2026.106861","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:48:05Z","timestamp":1784735285000},"page":"106861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eltrombopag use in surgical procedures in inherited thrombocytopenia: expanding the role of thrombopoietin-receptor agonists"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-2060","authenticated-orcid":false,"given":"Miguel de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106861_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12185-013-1351-7","article-title":"Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists","volume":"98","author":"Pecci","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2026.106861_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","article-title":"The biology of thrombopoietin and thrombopoietin receptor agonists","volume":"98","author":"Kuter","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2026.106861_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106861_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2022.280856","article-title":"Treatment of inherited thrombocytopenias","volume":"107","author":"Balduini","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106861_bib5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3324\/haematol.2016.160754","article-title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","volume":"102","author":"Orsini","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106861_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tracli.2018.07.003","article-title":"Inherited platelet disorders: management of the bleeding risk","volume":"25","author":"Dupuis","year":"2018","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.rpth.2026.106861_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cll.2021.07.005","article-title":"Platelet transfusion: an update on indications and guidelines","volume":"41","author":"Yuan","year":"2021","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.rpth.2026.106861_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.seminhematol.2019.10.001","article-title":"Platelet transfusion: alloimmunization and refractoriness","volume":"57","author":"Prodger","year":"2020","journal-title":"Semin Hematol"},{"key":"10.1016\/j.rpth.2026.106861_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/a-2250-9369","article-title":"Novel perspectives on thrombopoietin receptor agonists applications","volume":"45","author":"Stafylidis","year":"2025","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2026.106861_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12185-020-02918-6","article-title":"Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer","volume":"112","author":"Paciullo","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2026.106861_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MPH.0000000000001528","article-title":"Eltrombopag therapy in children with rare disorders associated with thrombocytopenia","volume":"42","author":"Fr\u0105czkiewicz","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.rpth.2026.106861_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.17174","article-title":"Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-Aldrich syndrome","volume":"192","author":"Khoreva","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106861_bib13","first-page":"1839","article-title":"Successful eltrombopag therapy in a child with MYH9-related inherited thrombocytopenia","volume":"9","author":"Lassandro","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.rpth.2026.106861_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1213\/XAA.0000000000000621","article-title":"Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report","volume":"10","author":"Favier","year":"2018","journal-title":"A A Pract"},{"key":"10.1016\/j.rpth.2026.106861_bib15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-09-602573","article-title":"Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome\/X-linked thrombocytopenia","volume":"126","author":"Gerrits","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106861_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/09537104.2017.1356920","article-title":"Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia","volume":"29","author":"Rabbolini","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2026.106861_bib17","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.3390\/ijms22094330","article-title":"Role of thrombopoietin receptor agonists in inherited thrombocytopenia","volume":"22","author":"Bastida","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2026.106861_bib18","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1002\/ajh.25500","article-title":"Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia","volume":"94","author":"Zaninetti","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106861_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3324\/haematol.2019.223966","article-title":"Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial","volume":"105","author":"Zaninetti","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106861_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2026.106861_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2014-08-594531","article-title":"ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization","volume":"125","author":"Bottega","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106861_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajhg.2013.01.015","article-title":"ACTN1 mutations cause congenital macrothrombocytopenia","volume":"92","author":"Kunishima","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2026.106861_bib23","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1182\/blood-2010-12-323691","article-title":"Heterozygous ITGA2B R995W mutation inducing constitutive activation of the \u03b1IIb\u03b23 receptor affects proplatelet formation and causes congenital macrothrombocytopenia","volume":"117","author":"Kunishima","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106861_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235136","article-title":"\u03b1IIb\u03b23 variants in ten families with autosomal dominant macrothrombocytopenia: expanding the mutational and clinical spectrum","volume":"15","author":"Morais","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106861_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/79069","article-title":"Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly","volume":"26","author":"Kelley","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.rpth.2026.106861_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.2011.08716.x","article-title":"Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias","volume":"154","author":"Balduini","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106861_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034449","article-title":"Outside-in signalling generated by a constitutively activated integrin \u03b1IIb\u03b23 impairs proplatelet formation in human megakaryocytes","volume":"7","author":"Bury","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106861_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J Clin Invest"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:56:23Z","timestamp":1790164583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926035193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2475037926035193"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106861","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eltrombopag use in surgical procedures in inherited thrombocytopenia: expanding the role of thrombopoietin-receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106861"}}